West Africa is one region of focus for Emerging World Pharma Inc.. Comprising almost a third of the whole continent, West Africa is a region with a population of approximately 250 million. Imports of finished products account for over 60% of the African pharmaceutical industry. According to IMS forecast, Nigeria’s Pharma business is worth $2.5 billion serving 150 million Nigerians. The pharmaceutical market in West Africa has been growing 5% - 7% annually. With over 200 active manufacturers of pharmaceuticals in West Africa, there are great opportunities for investment and development.
The developing market within the European pharmaceutical industry is another focus of Emerging World Pharma Inc.. With a market share of 18% by value, representing nearly half of the volume of medicines delivered to European citizens, the European generic medicines industry is currently a well-established and essential partner in European healthcare. Generic medicines represent 42% of the total pharmaceutical market volume with annual sales of more than €4 billion.